Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.09.2011 | Short review

Molecular genetic tests in the prediction of the prognosis of breast cancer

verfasst von: F. R. Stoddard II, A. M. Szasz, B. Szekely, A.-M. Tokes, J. Kulka

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten
Vorheriger Artikel The use of mammographic tumour feature significantly improves outcome prediction of breast cancers smaller than 15 mm: a reproducibility study from two comprehensive breast centres
Nächster Artikel Conventional and non-conventional pathologic workup of specimens with early breast carcinomas
Metadaten
Titel
Molecular genetic tests in the prediction of the prognosis of breast cancer
verfasst von
F. R. Stoddard II
A. M. Szasz
B. Szekely
A.-M. Tokes
J. Kulka
Publikationsdatum
01.09.2011
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2011
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-011-0285-0

Weitere Artikel der Ausgabe 3/2011

Conventional and non-conventional pathologic workup of specimens with early breast carcinomas

  • Short review

Skeletal Care Academy 2011 – CECOG Translational

  • CECOG News

The use of mammographic tumour feature significantly improves outcome prediction of breast cancers smaller than 15 mm: a reproducibility study from two comprehensive breast centres

  • Original report

Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2 versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group

  • Short review

History of treatment and long-term outcome of childhood acute lymphoblastic leukemia in Slovenia

  • Short review

History of treatment and long-term outcome in children with acute lymphoblastic leukaemia in Serbia

  • Short review